TNFRSF8 and neoplasm: We found that Karpas 299 transplanted tumor has a certain degree of variability, the tumor growth inhibitions of 3 mg/kg anti-CD30-MCC-DM1 were 71% (Figure 6(a)) and 92% (data are not shown) in two independent studies.